摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 912805-73-3

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
912805-73-3
化学式
C60H118O10Si5
mdl
——
分子量
1140.02
InChiKey
IWJWJUBRSLXBCQ-BAVNNYGOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    17.24
  • 重原子数:
    75.0
  • 可旋转键数:
    29.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.85
  • 拓扑面积:
    100.14
  • 氢给体数:
    0.0
  • 氢受体数:
    10.0

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthetic Studies of Complex Immunostimulants from Quillaja saponaria:  Synthesis of the Potent Clinical Immunoadjuvant QS-21Aapi
    摘要:
    QS-21 is one of the most promising new adjuvants for immune response potentiation and dose-sparing in vaccine therapy given its exceedingly high level of potency and its favorable toxicity profile. Melanoma, breast cancer, small cell lung cancer, prostate cancer, HIV-1, and malaria are among the numerous maladies targeted in more than 80 recent and ongoing vaccine therapy clinical trials involving QS-21 as a critical adjuvant component for immune response augmentation. QS-21 is a natural product immunostimulatory adjuvant, eliciting both T-cell- and antibody-mediated immune responses with microgram doses. Herein is reported the synthesis of QS-21A(api) in a highly modular strategy, applying novel glycosylation methodologies to a convergent construction of the potent saponin immunostimulant. The chemical synthesis of QS-21 offers unique opportunities to probe its mode of biological action through the preparation of otherwise unattainable nonnatural saponin analogues.
    DOI:
    10.1021/ja062364i
  • 作为产物:
    描述:
    (R)-(+)-5-(benzyloxy)-3-(tert-butyldimethylsilyloxy)pentanal 在 palladium on activated charcoal 4-二甲氨基吡啶 、 ruthenium trichloride 、 sodium periodate正丁基锂potassium tert-butylate氢气三乙胺 作用下, 以 四氢呋喃甲醇四氯化碳二氯甲烷甲苯乙腈 、 Petroleum ether 为溶剂, 反应 35.8h, 生成
    参考文献:
    名称:
    Synthetic Studies of Complex Immunostimulants from Quillaja saponaria:  Synthesis of the Potent Clinical Immunoadjuvant QS-21Aapi
    摘要:
    QS-21 is one of the most promising new adjuvants for immune response potentiation and dose-sparing in vaccine therapy given its exceedingly high level of potency and its favorable toxicity profile. Melanoma, breast cancer, small cell lung cancer, prostate cancer, HIV-1, and malaria are among the numerous maladies targeted in more than 80 recent and ongoing vaccine therapy clinical trials involving QS-21 as a critical adjuvant component for immune response augmentation. QS-21 is a natural product immunostimulatory adjuvant, eliciting both T-cell- and antibody-mediated immune responses with microgram doses. Herein is reported the synthesis of QS-21A(api) in a highly modular strategy, applying novel glycosylation methodologies to a convergent construction of the potent saponin immunostimulant. The chemical synthesis of QS-21 offers unique opportunities to probe its mode of biological action through the preparation of otherwise unattainable nonnatural saponin analogues.
    DOI:
    10.1021/ja062364i
点击查看最新优质反应信息